ATE63817T1 - Mischungen von fu und bvu als adenokarzinomhemmende mittel. - Google Patents

Mischungen von fu und bvu als adenokarzinomhemmende mittel.

Info

Publication number
ATE63817T1
ATE63817T1 AT88200265T AT88200265T ATE63817T1 AT E63817 T1 ATE63817 T1 AT E63817T1 AT 88200265 T AT88200265 T AT 88200265T AT 88200265 T AT88200265 T AT 88200265T AT E63817 T1 ATE63817 T1 AT E63817T1
Authority
AT
Austria
Prior art keywords
bvu
adenocarcinoma
mixtures
agents
bromovinyl
Prior art date
Application number
AT88200265T
Other languages
English (en)
Inventor
Clercq Erik De
Masaaki Iigo
Original Assignee
Stichting Rega V Z W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega V Z W filed Critical Stichting Rega V Z W
Application granted granted Critical
Publication of ATE63817T1 publication Critical patent/ATE63817T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88200265T 1987-02-13 1988-02-12 Mischungen von fu und bvu als adenokarzinomhemmende mittel. ATE63817T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8700366A NL8700366A (nl) 1987-02-13 1987-02-13 Combinatie van fu met bvdu als middel tegen adenocarcinoom.
EP88200265A EP0283065B1 (de) 1987-02-13 1988-02-12 Mischungen von FU und BVU als adenokarzinomhemmende Mittel

Publications (1)

Publication Number Publication Date
ATE63817T1 true ATE63817T1 (de) 1991-06-15

Family

ID=19849574

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88200265T ATE63817T1 (de) 1987-02-13 1988-02-12 Mischungen von fu und bvu als adenokarzinomhemmende mittel.

Country Status (8)

Country Link
US (2) US4894365A (de)
EP (1) EP0283065B1 (de)
JP (1) JP2688057B2 (de)
AT (1) ATE63817T1 (de)
DE (1) DE3862961D1 (de)
ES (1) ES2032942T3 (de)
GR (1) GR3002431T3 (de)
NL (1) NL8700366A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137724A (en) * 1990-05-23 1992-08-11 Stichting Rega Vzw Combinations of TS-inhibitors and viral TK-inhibitors in antiherpetic medicines
PT806956E (pt) * 1995-02-01 2003-01-31 Resprotect Gmbh Utilizacao de nucleosidos 5-substituidos para a inibicao de formacao de resistencia no tratamento com citostaticos
WO1999008110A1 (en) 1997-08-08 1999-02-18 Newbiotics, Inc. Methods and compositions for overcoming resistance to biologic and chemotherapy
WO1999037753A1 (en) 1998-01-23 1999-07-29 Newbiotics, Inc. Enzyme catalyzed therapeutic agents
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
MXPA02000762A (es) 1999-07-22 2002-08-20 Newbiotics Inc Metodos para tratar tumores resistentes a terapia.
WO2001045690A2 (en) * 1999-12-23 2001-06-28 Newbiotics, Inc. Use of bvdu for inhibiting the growth of hyperproliferative cells
DE10108851A1 (de) * 2001-02-23 2002-09-12 Resprotect Gmbh Verwendung von 5'-substituierten Nukleosiden und/oder deren Prodrugs zur resistenzfreien Therapie von Infektionskrankheiten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016921B (en) * 1978-03-27 1982-08-18 Taiho Pharmaceutical Co Ltd Anti cancer compositions containing uracil derivatives
IT1170232B (it) * 1983-10-31 1987-06-03 Anna Gioia Stendardi Composizioni terapeutiche ad attivita' antivirale
EP0189755B1 (de) * 1985-01-30 1990-01-03 F. Hoffmann-La Roche Ag Pharmazeutische Zusammensetzung

Also Published As

Publication number Publication date
JP2688057B2 (ja) 1997-12-08
GR3002431T3 (en) 1992-12-30
DE3862961D1 (de) 1991-07-04
EP0283065A1 (de) 1988-09-21
ES2032942T3 (es) 1996-07-16
EP0283065B1 (de) 1991-05-29
JPS63203619A (ja) 1988-08-23
US4988678A (en) 1991-01-29
NL8700366A (nl) 1988-09-01
US4894365A (en) 1990-01-16

Similar Documents

Publication Publication Date Title
FR2781218B1 (fr) Compositions pharmaceutiques comprenant des 2-quinolones
DE69129861D1 (de) Topische mittel zur transdermalen verabreichung von prodrugderivaten des morphins
ATE161432T1 (de) Spielzeugbausatz und bauelemente dafür
MX9101913A (es) Derivados de quinazolinas para potenciar la actividad antitumoral
TR200000437T2 (tr) Sinerjistik Biyosit bileşimi.
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
DE69714253D1 (de) Stickstoffoxydabgebendes präparat zur reduzierung der toxizität von wirkstoffen
GR3007385T3 (de)
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
ATE63817T1 (de) Mischungen von fu und bvu als adenokarzinomhemmende mittel.
NO853037L (no) Alfa-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3h)-yl)-benzeneacetonitriler.
SE8404065D0 (sv) Novel biologically active compounds
DK0636027T3 (da) Angiotensin-II-antogonister mod sygdomme forbundet med forringet neuronal ledningshastighed, især diabetisk neuropati
IT1212143B (it) Composizione ad attivita'tricogena.
GR3005870T3 (de)
DE69314463D1 (de) Hautregenerierende kosmetische zusammensetzung
FI911501A0 (fi) Liposomkomposition foer parenteralt bruk.
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
ATE93846T1 (de) S-substituierte beta-thioacrylamide und deren verwendung als mikrobizide.
ATE89732T1 (de) Bakterientoetende gemische.
NZ503008A (en) Synergistic antimicrobial compositions containing dodecylmorpholine or a salt thereof and dodecylamine or a salt thereof
DK189787D0 (da) Farmaceutiske praeparater til behandling af claudicatio intermittens
DK181089D0 (da) 1-dimethylcarbamoyl-3-substituerede-5-substituerede-1h-1,2,4-triazoler
ES2058784T3 (es) Composiciones quimicas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee